F2G
Tim Anderson is a Partner, Head of Research and a co-founding member of Cowen Healthcare Investments. He focuses on investments in life science and digital medicine companies that have the potential to meaningfully address serious medical conditions. Mr. Anderson is currently a member of the Board of Directors of F2G, Autobahn Therapeutics, Cadent Therapeutics, Cullinan Oncology and VectivBio. Mr. Anderson previously served as a Board Member or Observer of Therachon, Precision Biosciences, and Livongo Health.
Prior to his role at Cowen Healthcare Investments, Mr. Anderson was a biotechnology investment banker on Cowen’s healthcare investment banking team. Mr. Anderson holds a BA in economics from Bowdoin College.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
F2G
1 followers
F2G is a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapies to treat life-threatening invasive fungal infections.